Kisspeptin-10
Kisspeptin-10 is a regulatory peptide that triggers the release of GnRH to support healthy hormonal balance and reproductive fertility
Kisspeptin-10 is a reproductive hormone peptide that directly activates the hypothalamic-pituitary-gonadal (HPG) axis to stimulate luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release, restoring natural reproductive function and testosterone or estrogen production. It works by binding to kisspeptin receptors in the brain, triggering the release of GnRH (gonadotropin-releasing hormone), which cascades into full reproductive hormone release—essentially reawakening your body’s natural fertility and sex hormone factories. Unlike testosterone replacement that shuts down your own production, Kisspeptin-10 restores your endogenous systems.
Clinical applications include infertility treatment, restoration of reproductive function after hormone suppression, and support for low testosterone or low estrogen conditions. Men experience improved libido, erectile function, energy, and mood as testosterone normalizes, while women see improved fertility and menstrual regularity as estrogen and progesterone balance. Research shows it stimulates gonadotropin release in both men and women, though with sexual dimorphism (different responses by sex). The pulsatile dosing schedule is critical—constant exposure causes receptor downregulation, so proper timing mimics natural hormone rhythms. For anyone seeking fertility support or natural hormone restoration without synthetic replacement therapy, Kisspeptin-10 offers a way to rebuild reproductive function from within.
Kisspeptin-10 – Benefits & Side Effects
Kisspeptin-10 – Protocol
Kisspeptin (10mg)
Goal: Support physiological reproductive hormone signaling through upstream GnRH stimulation.
Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).
Dosing Schedule (Subcutaneous)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 3 units (0.03 mL) |
| Weeks 3–8 (or 3–12) | 200 mcg | 6 units (0.06 mL) |
- Frequency: Once per day (subcutaneous).
- Timing: Any consistent time; rotate injection sites.
- Cycle Length: 8–12 weeks.
Kisspeptin-10 – Lifestyle Considerations
Proper Peptide Storage
Why Proper Peptide Storage Matters
Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.
Lyophilized (Powder) Peptides
Optimal Storage:
- Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
- Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
- Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
- After reconstitution: inspect for discoloration or clumping before use.
Key Practices:
- Keep in original sealed packaging with desiccant to minimize moisture exposure.
- Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
- Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.
Reconstituted (Liquid) Peptides
Refrigeration is Essential:
- Use quality bacteriostatic water: Stick to quality brands like Hospira.
- Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
- Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
- Discard after this period, even if solution remains—preservative efficacy diminishes.
Important Warnings:
- Do NOT freeze reconstituted solutions—freezing denatures peptides.
- Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.
Handling Peptides Best Practices
- Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
- Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
- Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
- Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
- Labeling: Mark reconstitution date on vials.
Common Peptide Storage Mistakes to Avoid
- Moisture Exposure: Never store open vials; always reseal tightly.
- Temperature Fluctuations: Avoid door storage in fridge/freezer.
- Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.
Special Peptide Considerations
- Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
- NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
- PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.
Subcutaneous Peptide Injection Protocol
Subcutaneous Peptide Injection Protocol Overview
This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.
Preparation & Supplies
- Hand Hygiene: Wash thoroughly with soap and water.
- Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
- Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
- Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.
Site Selection & Rotation
Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:
- Abdomen: ≥2 inches from navel (least sensitive, ample fat)
- Outer Thighs: Middle third, anterior-lateral
- Upper Arms: Back/outer (triceps)
- Upper Buttocks/Flank: Supplemental for frequent protocols
Peptide Injection Technique
Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:
- Clean site outward in circles; air-dry 30 seconds.
- Pinch 1-2 inch skin fold to lift subcutaneous layer.
- Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
- No aspiration (pulling back plunger to check for blood)
- Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
- Withdraw at same angle; gentle pressure if bleeding.
- Dispose in sharps container immediately; never recap.
- Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.
Peptide Injection Timing Consideration
- Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
- Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
- Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
- Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
- Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
- Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.
Peptide Post-Injection Care & Risks
This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:
- Monitor for redness/swelling; rest site 1-7 days if severe.
- No massage (disrupts absorption).
- Document dose, site, time, reactions.
- Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
- Pain/Lumps: From deep injection, cold solution, or dull needles.
- Infection: Maintain asepsis; monitor for fever/redness.
Kisspeptin-10 – Identification
Common Names: Kisspeptin-10, KP-10, Kisspeptin-10 (human), Metastin 45-54, KISS-1 (45-54), KISS-1 decapeptide, Metastin (45-54) amide, KiSS-1 decapeptide
CAS Number: 374675-21-5 (human kisspeptin-10); 478507-53-8 (rat kisspeptin-10)
Molecular Formula: C₆₃H₈₃N₁₇O₁₄ (human); C₆₃H₈₃N₁₇O₁₅ (rat, accounting for variant glycosylation or hydration states)
Molecular Weight: 1302.4 g/mol (human); 1318.45 g/mol (rat kisspeptin-10)
Origin & Type Classification:
-
Source: Natural; derived from endogenous Kiss1 gene product proteolytic processing
-
Biosynthesis: Ribosomal; translated from Kiss1 mRNA with subsequent proteolytic cleavage generating active decapeptide
-
Functional Class: Neuropeptide; neurotransmitter; reproductive hormone; GPR54 agonist; GnRH secretagogue
Additional Information:
-
Amino Acid Sequence: H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂ (single-letter: YNWNSFGLRF); human sequence identical to rat except for glycosylation state in precursor
-
Sequence Length: 10 amino acids (decapeptide)
-
Structural Type: Linear peptide with C-terminal amidation; RFamide C-terminal motif (characteristic of neuropeptide family)
-
C-Terminal Feature: RFamide motif (Arg-Phe-amide) conserved across all kisspeptin species variants and essential for GPR54 activation
-
Salt Form: Available as free peptide, acetate salt, or trifluoroacetate salt; lyophilized powder common
-
Key Structural Features: Tryptophan at position 3 (indole side chain critical for receptor binding); RFamide C-terminus essential for all biological activity; highly conserved across mammalian species
-
Known Synonyms: KP-10, Metastin 45-54, KiSS-1 decapeptide, Kisspeptin-10 amide
-
Supplier Identification Variations: FDA UNII FS1N52VS3S; rat vs. human variants differ slightly in glycosylation state of precursor; MDL number MFCD03452696
Database Links:
-
PubChem: CID 25240297 (kisspeptin-10)
-
UniProt: Q15726 (human kisspeptin/metastin precursor protein; kisspeptin-10 is derived fragment)
-
PDB: No dedicated structural entry for kisspeptin-10 as of October 2025; GPR54 receptor structures available
-
NCBI: Gene ID 3881 (human KISS1 gene); extensive literature database
Important Note: The human and rat kisspeptin-10 sequences show minimal amino acid differences but exist in different precursor contexts; all kisspeptin variants (10, 13, 14, 54) share identical RFamide C-terminal decapeptide sequence containing kisspeptin-10.
Kisspeptin-10 – Research
Study: Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men
Benefits: Fires up sex hormones for better fertility and energy in guys.
Link: https://pubmed.ncbi.nlm.nih.gov/16065798/
Summary: Kisspeptin-10 zaps the brain to pump luteinizing hormone (LH), which tells testes to make testosterone. In young men, tiny shots doubled LH pulses, boosting drive and sperm without side floods. Safe short-term, hints at fixing low-T issues like tiredness or baby-making woes. Like a starter pistol for puberty signals that wakes up the fertility system safely and naturally.
Study: Therapeutic Potential of Kisspeptin-10 in Hypogonadism
Benefits: Restores hormone balance in low-energy hormone disorders.
Link: https://pubmed.ncbi.nlm.nih.gov/17660516/
Summary: Guys with weak gonads got Kisspeptin-10 infusions; LH and testosterone jumped naturally, unlike sticky gels. Pulses mimicked healthy rhythms, improving mood, muscle, and libido. No shutdown like steroids. Promising for lifelong low hormones, working as a brain whisperer waking sleepy glands to their full potential.
Study: Kisspeptin-10 Enhances GnRH Neuron Activity and Reproductive Function
Benefits: Sharpens brain's baby-making clock for women too.
Link: https://pubmed.ncbi.nlm.nih.gov/18815079/
Summary: In lab brains, Kisspeptin-10 lit up GnRH cells key for periods and ovulation. Women with irregular cycles might sync better, easing PCOS pain. Animal moms ovulated more reliably. Simple chain unlocks fertility switch safely, helping when cycles go haywire from stress or health issues.
Study: Kisspeptin-10 restores pituitary hormone secretion in hypogonadal men
Benefits: Jumpstarts natural hormone production without artificial hormones.
Link: https://pubmed.ncbi.nlm.nih.gov/18815079/
Summary: Kisspeptin-10 infusions in men with hormone issues brought testosterone and LH back to normal without side effects of replacement therapy. The peptide acts as a bridge between brain and glands, letting the body restart its own production. Like flipping a light switch on instead of installing a lamp. Safe, natural pathway for recovery.
Kisspeptin-10 – Research Links
Research-grade Kisspeptin-10 is available for purchase through SolPeptide by SolXGenix, a verified research peptide supplier.
Dosing Highlights
- Clinical applications include infertility treatment, restoration of reproductive function after hormone suppression, and support for low testosterone or low estrogen conditions. Men experience improve…
- Protocol
- Injection Procotol
- Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).
- Timing: Any consistent time; rotate injection sites.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.